Pregnancy-associated plasma protein predicts outcomes of percutaneous coronary intervention in patients with non-ST-elevation acute coronary syndrome

Heart and Lung: Journal of Acute and Critical Care

Volumn 40, Issue 3, 2011, Pages

  Mei, Wei Yi ^a   Du, Zhi Min ^a   Zhao, Qiang ^b   Hu, Cheng Heng ^a   Li, Yi ^a   Luo, Chu Fan ^a   Wu, Gui Fu ^a   Chen, Guo Wei ^a   Wang, Le Xin ^c  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGZHOU RED CROSS HOSPITAL   (China)

^c CHARLES STURT UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ACUTE CORONARY SYNDROME; ADULT; ANGINA PECTORIS; ARTICLE; CORONARY ARTERY OBSTRUCTION; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGINA, UNSTABLE; ANGIOPLASTY, BALLOON, CORONARY; CHINA; CONFIDENCE INTERVALS; CORONARY STENOSIS; CRITICAL CARE; FEMALE; HUMANS; MALE; MATHEMATICAL COMPUTING; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PROGNOSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 79955521183     PISSN: 01479563     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrtlng.2010.06.006     Document Type: Article

References (18)

1. Bayes-Genis A., Conover C.A., Bailey K.R., et al. Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. N Engl J Med 2001, 345:1022-1029.
2. Liu Z.Y., Zhang J.Y., Sun T.W., Zhang Y.J., Zhang L., Wang L.X. Levels of pregnancy-associated plasma protein A and insulin-like growth factor-1 in patients with coronary artery disease. Clin Invest Med 2008, 31:E85-E89.
3. Cosin-Sales J., Kaski J.C., Christiansen M., et al. Relationship among pregnancy associated plasma protein-A levels, clinical characteristics, and coronary artery disease extent in patients with chronic stable angina pectoris. Eur Heart J 2005, 26:2093-2098.
4. Cosin-Sales J., Christiansen M., Kaminski P., et al. Pregnancy-associated plasma protein A and its endogenous inhibitor, the proform of eosinophil major basic protein (proMBP), are related to complex stenosis morphology in patients with stable angina pectoris. Circulation 2004, 109:1724-1728.
5. Lund J., Qin Q.P., Ilva T., et al. Circulating pregnancy-associated plasma protein predicts outcome inpatients with acute coronary syndrome but no troponin I elevation. Circulation 2003, 108:1924-1926.
6. Heeschen C., Dimmeler S., Hamm C.W., et al. Investigators CS. Pregnancy-associated plasma protein-A levels inpatients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis. J Am Coll Cardiol 2005, 45:229-237.
7. Qin Q.P., Laitinen P., Majamaa-Voltti K., Eriksson S., Kumpula E.K., Pettersson K. Release patterns of pregnancy associated plasma protein A (PAPP-A) in patients with acute coronary syndromes. Scand Cardiovasc J 2002, 36:358-361.
8. Overgaard M.T., Haaning J., Boldt H.B., et al. Expression of recombinant human pregnancy-associated plasma protein-A and identification of the proform of eosinophil major basic protein as its physiological inhibitor. J Biol Chem 2000, 275:31128-31133.
9. The T.I.M.I. Study Group. The thrombolysis in myocardial infarction (TIMI) trial: phase I findings. N Engl J Med 1985, 312:932-936.
10. Gibson C.M., Cannon C.P., Murphy S.A., et al. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation 2000, 101:125-130.
11. Elesber A.A., Lerman A., Denktas A.E., et al. Pregnancy associated plasma protein-A and risk stratification of patients presenting with chest pain in the emergency department. Int J Cardiol 2007, 117:365-369.
12. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 2001, 104:365-372.
13. Jones J.I., Prevette T., Gockerman A., Clemmons D.R. Ligand occupancy of the alfa-V-beta3 integrin is necessary for smooth muscle cells to migrate in response to insulin-like growth factor. Proc Natl Acad Sci U S A 1996, 93:2482-2487.
14. Iversen K.K., Teisner A.S., Teisner B., et al. Pregnancy associated plasma protein A, a potential marker for vulnerable plaque in patients with non-ST-segment elevation acute coronary syndrome. Clin Biochem 2009, 42:828-834.
15. Smith S.C., Feldman T.E., Hirshfeld J.W., et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol 2006, 47:e1-e121.
16. Chew D.P., Bhatt D.L., Robbins M.A., et al. Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention. Circulation 2001, 104:992-997.
17. Razzouk L., Muntner P., Bansilal S., et al. C-reactive protein predicts long-term mortality independently of low-density lipoprotein cholesterol in patients undergoing percutaneous coronary intervention. Am Heart J 2009, 158:277-283.
18. Li X.P., Zhou S.H., Tang J.J., et al. Association between plasma pregnancy-associated plasma protein A and restenosis after percutaneous coronary angioplasty. Circ J 2008, 72:729-733.